In 2014, upon evaluation needs for IBD patients and health care providers, IBD Unit specialists at the University of Alberta and the University of Calgary, collaboratively developed the IBD Clinical Care Pathways (IBD CCPs©)
They are structured, standardized, evidence-based multidisciplinary management algorithms, identifying an appropriate sequence of clinical interventions and timeframes for IBD patients
These IBD CCPs© are supported by systematic reviews of published evidence and are comprised of protocols, algorithms, and checklists that help to harmonize clinical and administrative aspects and ensure continuity of IBD care in outpatient setting
Optimal management of IBD flare, including complains and history assessment, timelines and laboratory/diagnostic imaging investigations
Safe induction of Biologic therapy
Appropriate management of patients biologic therapy, including optimization, maintenance and follow-up timelines
Informed family planning and safety during pregnancy
Management of IBD patients on no immunosuppressants or biologic therapy, follow-up timelines
Management of systemic steroid therapy, including induction, maintenance, withdrawal, and side-effects monitoring
Appropriate initiation and use of immunomodulators (thiopurines and methotrexate)
Highlights of indications and important timelines for surveillance
Provide direction regarding choice of therapy for patients with Crohn’s disease
Achieve and maintain remission with biologic therapy
Provide direction to management of patients with perianal Crohn’s disease
Provide direction for management of patients with Crohn’s disease after a bowel resection
Provide direction regarding choice of therapy for patients with ulcerative colitis
Supplemental Material
Comprehensive collection of biologics- and biosimilars-related documents and forms
To contact the clinical care pathway team please email: ibdpaths@ualberta.ca